Subscribe
Machinery & Materials
Markets
Logistics & Cold Chain
Issues
Events
Newsletters
Cryoport
More from Cryoport
Home
Cryoport, World Courier Ink Logistics Deal for Gene Therapies
Partnership to support the delivery of cell and gene therapies globally with a full suite of temperature-controlled products.
Home
Cryoport, World Courier Ink Logistics Deal for Gene Therapies
Partnership to support the delivery of cell and gene therapies globally with a full suite of temperature-controlled products.
Home
Cryoport: Cryoport. Certified. Cool.
The C3 ™ shipper is designed to provide cold chain logistics in the 2°C – 8°C temperature range for regenerative therapy requirements.
Pharmaceutical
Cryoport: Cryoport. Certified. Cool.
The C3 ™ shipper is designed to provide cold chain logistics in the 2°C – 8°C temperature range for regenerative therapy requirements.
Home
Novartis, Cryoport Reach Logistics Agreement
Three-year agreement provides cryogenic logistics support for launch of potential treatment for relapsed/refractory acute lymphoblastic leukemia.
Home
Determining the Impact of Packaging and Logistics on the CAR-T Clinical Pipeline
Sept. 14 presentation addresses the systematic study of the impact of logistics decisions on the integrity of critical biomarkers and active clinical product and data generation.
Logistics/supply chain
Determining the Impact of Packaging and Logistics on the CAR-T Clinical Pipeline
Sept. 14 presentation addresses the systematic study of the impact of logistics decisions on the integrity of critical biomarkers and active clinical product and data generation.
Home
Logistics Study to Evaluate Temperature and Transport Packaging
KCAS and Heat Biologics partner with Cryoport on critical bioanalytical materials and their influence on the data generated and required to support drug development programs.
Home
Logistics Study to Evaluate Temperature and Transport Packaging
KCAS and Heat Biologics partner with Cryoport on critical bioanalytical materials and their influence on the data generated and required to support drug development programs.
